GI
FULC icon

GAMMA Investing’s Fulcrum Therapeutics FULC Stock Holding History

GAMMA Investing’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.33K Buy
+360
New +$1.35K ﹤0.01% 4044
2026
Q1 		– Sell
-25
Closed -$283 – 4165
2025
Q4 		$283 Buy
+25
New +$254 ﹤0.01% 3972
2024
Q4 		– Sell
-198
Closed -$707 – 3796
2024
Q3 		$707 Buy
+198
New +$1.47K ﹤0.01% 3337
2024
Q2 		– Sell
-45
Closed -$425 – 3480
2024
Q1 		$425 Buy
+45
New +$402 ﹤0.01% 3129

Other funds holding FULC

CP
Castleview Partners Dallas, Texas $228M AUM 13.32% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GAMMA Investing's FULC Position: Q3 2026 in Review

GAMMA Investing opened a new position in Fulcrum Therapeutics (FULC) in Q3 2026: 360 shares worth $1.33K. The stake represents ﹤0.01% of the portfolio and ranks #4044 among its holdings. This is a return to the name: GAMMA Investing previously reported a position in FULC as recently as Q4 2025.

GAMMA Investing first reported a position in FULC in Q1 2024 and has held it in 4 quarters since. 4 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • GAMMA Investing held 360 shares of Fulcrum Therapeutics worth $1.33K as of Q3 2026.
  • Fulcrum Therapeutics was a new GAMMA Investing position in Q3 2026.
  • Fulcrum Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4044 holding.
  • GAMMA Investing first reported a position in Fulcrum Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • 4 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.